Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clinical Trials as Topic | 31 | 2023 | 8000 | 3.980 |
Why?
|
Drug Approval | 13 | 2023 | 812 | 3.060 |
Why?
|
National Institutes of Health (U.S.) | 6 | 2023 | 793 | 2.720 |
Why?
|
United States Food and Drug Administration | 16 | 2023 | 1661 | 2.620 |
Why?
|
Legislation, Drug | 4 | 2023 | 214 | 2.150 |
Why?
|
Device Approval | 3 | 2023 | 163 | 1.850 |
Why?
|
Pediatrics | 14 | 2021 | 3589 | 1.730 |
Why?
|
Rare Diseases | 5 | 2019 | 623 | 1.660 |
Why?
|
Drug Prescriptions | 5 | 2023 | 1669 | 1.570 |
Why?
|
Research Support as Topic | 9 | 2020 | 697 | 1.540 |
Why?
|
Research Design | 14 | 2023 | 6178 | 1.500 |
Why?
|
Publishing | 7 | 2021 | 832 | 1.460 |
Why?
|
Product Surveillance, Postmarketing | 4 | 2023 | 452 | 1.420 |
Why?
|
Information Dissemination | 6 | 2023 | 1126 | 1.410 |
Why?
|
Patient Selection | 6 | 2023 | 4245 | 1.400 |
Why?
|
Drug Industry | 10 | 2024 | 788 | 1.290 |
Why?
|
Child | 74 | 2024 | 80134 | 1.270 |
Why?
|
Research | 3 | 2021 | 1975 | 1.230 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2024 | 10213 | 1.220 |
Why?
|
Emergency Service, Hospital | 22 | 2023 | 7873 | 1.120 |
Why?
|
Drug Utilization | 4 | 2019 | 1188 | 1.100 |
Why?
|
Neuraminidase | 3 | 2016 | 195 | 1.100 |
Why?
|
Pharmaceutical Preparations | 4 | 2022 | 1086 | 0.980 |
Why?
|
United States | 56 | 2024 | 72337 | 0.980 |
Why?
|
Hospitals, Pediatric | 10 | 2022 | 1860 | 0.970 |
Why?
|
Cost of Illness | 6 | 2021 | 1937 | 0.970 |
Why?
|
Drug Labeling | 5 | 2020 | 248 | 0.930 |
Why?
|
Research Subjects | 2 | 2017 | 249 | 0.910 |
Why?
|
Anticonvulsants | 3 | 2022 | 1911 | 0.900 |
Why?
|
Pharyngitis | 2 | 2022 | 220 | 0.880 |
Why?
|
Conflict of Interest | 5 | 2024 | 554 | 0.870 |
Why?
|
Durable Medical Equipment | 1 | 2023 | 23 | 0.870 |
Why?
|
Biopharmaceutics | 1 | 2022 | 23 | 0.840 |
Why?
|
Research Report | 4 | 2020 | 367 | 0.820 |
Why?
|
Analgesics, Opioid | 8 | 2023 | 3808 | 0.780 |
Why?
|
Adolescent | 49 | 2024 | 88271 | 0.770 |
Why?
|
Biomedical Research | 8 | 2020 | 3429 | 0.740 |
Why?
|
Financial Support | 1 | 2021 | 116 | 0.740 |
Why?
|
Off-Label Use | 2 | 2020 | 185 | 0.730 |
Why?
|
Streptococcal Infections | 2 | 2022 | 617 | 0.730 |
Why?
|
Drug Information Services | 2 | 2018 | 51 | 0.720 |
Why?
|
Control Groups | 1 | 2020 | 104 | 0.710 |
Why?
|
Orphan Drug Production | 2 | 2018 | 48 | 0.710 |
Why?
|
Information Storage and Retrieval | 3 | 2020 | 818 | 0.690 |
Why?
|
Financing, Government | 2 | 2022 | 472 | 0.680 |
Why?
|
European Union | 4 | 2023 | 157 | 0.670 |
Why?
|
Hospitalization | 9 | 2022 | 10712 | 0.670 |
Why?
|
Humans | 129 | 2024 | 761098 | 0.670 |
Why?
|
Selection Bias | 2 | 2019 | 359 | 0.660 |
Why?
|
Databases as Topic | 2 | 2020 | 473 | 0.660 |
Why?
|
Scientific Misconduct | 1 | 2020 | 74 | 0.660 |
Why?
|
Government Regulation | 2 | 2024 | 524 | 0.660 |
Why?
|
Ambulatory Care | 3 | 2019 | 2769 | 0.650 |
Why?
|
Benzodiazepines | 2 | 2023 | 1134 | 0.650 |
Why?
|
Influenza, Human | 5 | 2014 | 1521 | 0.640 |
Why?
|
Bronchiolitis | 2 | 2023 | 485 | 0.640 |
Why?
|
Cross-Sectional Studies | 23 | 2024 | 26068 | 0.620 |
Why?
|
Acetaminophen | 2 | 2021 | 555 | 0.620 |
Why?
|
Neglected Diseases | 1 | 2019 | 66 | 0.610 |
Why?
|
Emergency Treatment | 2 | 2015 | 495 | 0.600 |
Why?
|
Registries | 15 | 2023 | 8236 | 0.600 |
Why?
|
Respiratory Tract Infections | 2 | 2021 | 1009 | 0.600 |
Why?
|
Review Literature as Topic | 3 | 2016 | 347 | 0.580 |
Why?
|
Child, Preschool | 32 | 2021 | 42217 | 0.570 |
Why?
|
Authorship | 2 | 2019 | 284 | 0.560 |
Why?
|
Access to Information | 1 | 2020 | 316 | 0.560 |
Why?
|
Neoplasms | 6 | 2023 | 22125 | 0.550 |
Why?
|
PubMed | 3 | 2022 | 129 | 0.550 |
Why?
|
Drug and Narcotic Control | 1 | 2018 | 144 | 0.550 |
Why?
|
Publication Bias | 3 | 2021 | 160 | 0.540 |
Why?
|
Health Care Surveys | 6 | 2019 | 2424 | 0.540 |
Why?
|
Enzyme Inhibitors | 3 | 2016 | 3700 | 0.540 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 69 | 0.530 |
Why?
|
Analgesics | 3 | 2021 | 1067 | 0.530 |
Why?
|
Placebos | 1 | 2020 | 1666 | 0.530 |
Why?
|
Minority Groups | 1 | 2023 | 1201 | 0.520 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.510 |
Why?
|
Infant | 29 | 2021 | 36164 | 0.510 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2017 | 219 | 0.510 |
Why?
|
Cardiovascular System | 1 | 2022 | 836 | 0.480 |
Why?
|
Developing Countries | 4 | 2020 | 2862 | 0.480 |
Why?
|
Pandemics | 9 | 2024 | 8663 | 0.470 |
Why?
|
Publications | 4 | 2023 | 194 | 0.450 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1228 | 0.450 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2023 | 1425 | 0.440 |
Why?
|
Epilepsy | 2 | 2022 | 3304 | 0.430 |
Why?
|
Databases, Bibliographic | 3 | 2018 | 130 | 0.430 |
Why?
|
Neuropsychiatry | 1 | 2013 | 76 | 0.420 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2017 | 774 | 0.420 |
Why?
|
Age Factors | 12 | 2020 | 18385 | 0.420 |
Why?
|
Periodicals as Topic | 4 | 2019 | 1463 | 0.400 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.380 |
Why?
|
Drug Interactions | 1 | 2016 | 1417 | 0.370 |
Why?
|
Drug Costs | 1 | 2019 | 1183 | 0.360 |
Why?
|
Retrospective Studies | 25 | 2024 | 80673 | 0.360 |
Why?
|
Developed Countries | 1 | 2013 | 448 | 0.360 |
Why?
|
Infant, Newborn | 15 | 2021 | 26187 | 0.360 |
Why?
|
Medical Informatics | 1 | 2018 | 733 | 0.360 |
Why?
|
Prescription Drugs | 2 | 2019 | 631 | 0.360 |
Why?
|
Drug Therapy | 1 | 2013 | 503 | 0.360 |
Why?
|
Program Development | 1 | 2017 | 1292 | 0.360 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 521 | 0.350 |
Why?
|
Drugs, Investigational | 1 | 2012 | 212 | 0.350 |
Why?
|
Mental Health | 2 | 2024 | 3251 | 0.350 |
Why?
|
Internet | 4 | 2014 | 3094 | 0.340 |
Why?
|
Young Adult | 16 | 2024 | 59199 | 0.340 |
Why?
|
Comparative Effectiveness Research | 2 | 2012 | 709 | 0.340 |
Why?
|
Endovascular Procedures | 1 | 2023 | 2181 | 0.330 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1921 | 0.320 |
Why?
|
Hypoglycemic Agents | 3 | 2020 | 3086 | 0.320 |
Why?
|
Drug Evaluation | 1 | 2010 | 641 | 0.320 |
Why?
|
Long QT Syndrome | 1 | 2013 | 466 | 0.310 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1615 | 0.310 |
Why?
|
Patient Admission | 2 | 2014 | 1365 | 0.310 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 12145 | 0.300 |
Why?
|
Equipment Safety | 2 | 2022 | 249 | 0.300 |
Why?
|
Polypharmacy | 1 | 2010 | 306 | 0.290 |
Why?
|
Population Surveillance | 3 | 2007 | 2599 | 0.290 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2009 | 365 | 0.290 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2009 | 149 | 0.280 |
Why?
|
Patient Access to Records | 1 | 2008 | 119 | 0.280 |
Why?
|
Crowding | 1 | 2008 | 142 | 0.280 |
Why?
|
Drug Discovery | 1 | 2014 | 1049 | 0.270 |
Why?
|
Male | 41 | 2024 | 360675 | 0.270 |
Why?
|
Female | 42 | 2024 | 392458 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2133 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3094 | 0.260 |
Why?
|
Outpatients | 4 | 2024 | 1596 | 0.260 |
Why?
|
Patient Dropouts | 1 | 2008 | 411 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3216 | 0.250 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1176 | 0.250 |
Why?
|
Medical Oncology | 3 | 2023 | 2316 | 0.250 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2164 | 0.240 |
Why?
|
Respiratory Protective Devices | 2 | 2021 | 47 | 0.230 |
Why?
|
Marketing | 2 | 2018 | 220 | 0.230 |
Why?
|
Time Factors | 5 | 2019 | 39953 | 0.230 |
Why?
|
Electronic Health Records | 1 | 2021 | 4813 | 0.220 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13630 | 0.220 |
Why?
|
Disclosure | 2 | 2020 | 747 | 0.210 |
Why?
|
Nervous System Diseases | 2 | 2013 | 1663 | 0.210 |
Why?
|
Endoleak | 1 | 2023 | 111 | 0.210 |
Why?
|
Automation | 3 | 2023 | 585 | 0.210 |
Why?
|
Hospitals, General | 1 | 2007 | 798 | 0.200 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1790 | 0.200 |
Why?
|
Antiviral Agents | 1 | 2014 | 3048 | 0.200 |
Why?
|
Disease | 1 | 2007 | 670 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1191 | 0.190 |
Why?
|
Adult | 22 | 2024 | 221083 | 0.190 |
Why?
|
Accreditation | 1 | 2024 | 473 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 849 | 0.180 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7405 | 0.180 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 337 | 0.170 |
Why?
|
Minors | 1 | 2020 | 58 | 0.170 |
Why?
|
Cellulitis | 1 | 2002 | 208 | 0.170 |
Why?
|
Sterilization | 1 | 2021 | 132 | 0.170 |
Why?
|
Manuscripts as Topic | 1 | 2019 | 15 | 0.170 |
Why?
|
Streptococcus pyogenes | 1 | 2022 | 292 | 0.170 |
Why?
|
Editorial Policies | 2 | 2018 | 458 | 0.170 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3063 | 0.170 |
Why?
|
Systems Analysis | 1 | 2020 | 169 | 0.170 |
Why?
|
Fraud | 1 | 2020 | 66 | 0.170 |
Why?
|
Databases, Factual | 5 | 2021 | 7969 | 0.160 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3707 | 0.160 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 326 | 0.160 |
Why?
|
Rabies | 1 | 2019 | 54 | 0.160 |
Why?
|
Leishmaniasis | 1 | 2019 | 67 | 0.160 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 951 | 0.150 |
Why?
|
Models, Statistical | 3 | 2024 | 5077 | 0.150 |
Why?
|
Logistic Models | 5 | 2019 | 13254 | 0.150 |
Why?
|
Hypolipidemic Agents | 2 | 2013 | 609 | 0.150 |
Why?
|
Industry | 1 | 2020 | 364 | 0.150 |
Why?
|
Wounds and Injuries | 3 | 2019 | 2492 | 0.150 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 628 | 0.150 |
Why?
|
International Cooperation | 2 | 2024 | 1423 | 0.150 |
Why?
|
Orchitis | 1 | 2017 | 35 | 0.140 |
Why?
|
Epididymitis | 1 | 2017 | 37 | 0.140 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 731 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 610 | 0.140 |
Why?
|
Spermatic Cord Torsion | 1 | 2017 | 72 | 0.140 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1376 | 0.140 |
Why?
|
Policy | 1 | 2020 | 506 | 0.140 |
Why?
|
Prevalence | 4 | 2019 | 15717 | 0.130 |
Why?
|
Health Promotion | 1 | 2008 | 2205 | 0.130 |
Why?
|
Dengue | 1 | 2019 | 254 | 0.130 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 988 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.120 |
Why?
|
MEDLINE | 1 | 2015 | 119 | 0.120 |
Why?
|
Pyridones | 1 | 2020 | 809 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1246 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3133 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2019 | 1741 | 0.120 |
Why?
|
Compassionate Use Trials | 1 | 2014 | 50 | 0.110 |
Why?
|
Bibliometrics | 1 | 2018 | 352 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1045 | 0.110 |
Why?
|
Occupational Exposure | 2 | 2021 | 1814 | 0.110 |
Why?
|
Therapies, Investigational | 1 | 2014 | 111 | 0.110 |
Why?
|
Papillomavirus Vaccines | 1 | 2020 | 496 | 0.110 |
Why?
|
Life Tables | 1 | 2013 | 364 | 0.110 |
Why?
|
Hospital Charges | 1 | 2015 | 350 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4013 | 0.110 |
Why?
|
Poison Control Centers | 1 | 2013 | 76 | 0.110 |
Why?
|
Risk | 2 | 2022 | 9614 | 0.110 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 116 | 0.110 |
Why?
|
Metformin | 1 | 2020 | 906 | 0.100 |
Why?
|
Probability | 2 | 2009 | 2478 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1878 | 0.100 |
Why?
|
World Health Organization | 1 | 2019 | 1321 | 0.100 |
Why?
|
Waiting Lists | 2 | 2008 | 765 | 0.100 |
Why?
|
Comorbidity | 2 | 2021 | 10514 | 0.100 |
Why?
|
Health Policy | 2 | 2024 | 2680 | 0.100 |
Why?
|
Data Collection | 2 | 2013 | 3319 | 0.090 |
Why?
|
Aged | 7 | 2023 | 169266 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7240 | 0.090 |
Why?
|
Sample Size | 1 | 2014 | 841 | 0.090 |
Why?
|
Incidence | 3 | 2020 | 21357 | 0.090 |
Why?
|
Cohort Studies | 5 | 2023 | 41486 | 0.090 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2010 | 34 | 0.090 |
Why?
|
Massachusetts | 5 | 2015 | 8836 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 748 | 0.090 |
Why?
|
Steroids | 1 | 2016 | 929 | 0.090 |
Why?
|
Evidence-Based Medicine | 2 | 2013 | 3689 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1386 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2024 | 64670 | 0.080 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1178 | 0.080 |
Why?
|
Pyrazoles | 1 | 2020 | 2010 | 0.080 |
Why?
|
Health Surveys | 1 | 2019 | 4036 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3688 | 0.080 |
Why?
|
Operating Rooms | 1 | 2016 | 790 | 0.080 |
Why?
|
Sweden | 1 | 2012 | 1379 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2012 | 273 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58946 | 0.080 |
Why?
|
Financing, Organized | 1 | 2010 | 204 | 0.080 |
Why?
|
Fever | 1 | 2016 | 1618 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 54419 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2813 | 0.080 |
Why?
|
Europe | 1 | 2015 | 3422 | 0.080 |
Why?
|
Utilization Review | 1 | 2009 | 382 | 0.080 |
Why?
|
Spinal Injuries | 1 | 2011 | 300 | 0.070 |
Why?
|
Drug Design | 1 | 2013 | 1045 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2013 | 1242 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9648 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2022 | 3743 | 0.070 |
Why?
|
Occupational Health Services | 1 | 2008 | 150 | 0.070 |
Why?
|
Hospitals | 2 | 2021 | 3881 | 0.070 |
Why?
|
Income | 1 | 2015 | 1868 | 0.070 |
Why?
|
Boston | 3 | 2016 | 9324 | 0.070 |
Why?
|
Mammography | 1 | 2017 | 2430 | 0.070 |
Why?
|
Age Distribution | 2 | 2009 | 2873 | 0.070 |
Why?
|
Virus Cultivation | 1 | 2006 | 88 | 0.070 |
Why?
|
Length of Stay | 2 | 2019 | 6420 | 0.070 |
Why?
|
Trauma Centers | 1 | 2011 | 936 | 0.060 |
Why?
|
Craniocerebral Trauma | 1 | 2010 | 490 | 0.060 |
Why?
|
Decision Trees | 1 | 2007 | 505 | 0.060 |
Why?
|
Middle Aged | 8 | 2020 | 220835 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2165 | 0.060 |
Why?
|
Cervical Vertebrae | 1 | 2011 | 976 | 0.060 |
Why?
|
Research Personnel | 2 | 2020 | 588 | 0.060 |
Why?
|
Computer-Assisted Instruction | 1 | 2008 | 362 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5070 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3536 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20120 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2278 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39121 | 0.060 |
Why?
|
Spinal Puncture | 1 | 2006 | 282 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12467 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.060 |
Why?
|
International Classification of Diseases | 1 | 2009 | 913 | 0.060 |
Why?
|
Medical History Taking | 1 | 2007 | 773 | 0.050 |
Why?
|
Seasons | 2 | 2006 | 1517 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 934 | 0.050 |
Why?
|
Risk Factors | 4 | 2016 | 74219 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3450 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9317 | 0.050 |
Why?
|
Viruses | 1 | 2006 | 372 | 0.050 |
Why?
|
Crying | 1 | 2002 | 37 | 0.050 |
Why?
|
Workplace | 1 | 2008 | 864 | 0.050 |
Why?
|
Olfactory Bulb | 1 | 2022 | 197 | 0.050 |
Why?
|
Endpoint Determination | 1 | 2024 | 590 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5425 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2003 | 500 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2021 | 45 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6818 | 0.050 |
Why?
|
Smell | 1 | 2022 | 259 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4319 | 0.040 |
Why?
|
Syncope | 1 | 2003 | 428 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5427 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2577 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6385 | 0.040 |
Why?
|
Virus Diseases | 1 | 2006 | 716 | 0.040 |
Why?
|
Child, Hospitalized | 1 | 2021 | 182 | 0.040 |
Why?
|
Syndrome | 1 | 2006 | 3269 | 0.040 |
Why?
|
Computer Simulation | 2 | 2024 | 6225 | 0.040 |
Why?
|
Government | 1 | 2020 | 160 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 288 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 601 | 0.040 |
Why?
|
Masks | 1 | 2021 | 208 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2024 | 2855 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 196 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 478 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 318 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2008 | 2316 | 0.040 |
Why?
|
Poverty | 2 | 2020 | 2692 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2021 | 368 | 0.040 |
Why?
|
Medical Records | 1 | 2003 | 1409 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1005 | 0.040 |
Why?
|
Health Expenditures | 1 | 2009 | 2363 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12058 | 0.030 |
Why?
|
Risk Assessment | 2 | 2009 | 24013 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15845 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10552 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2018 | 153 | 0.030 |
Why?
|
Health Behavior | 1 | 2008 | 2641 | 0.030 |
Why?
|
Regression Analysis | 1 | 2006 | 6343 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2706 | 0.030 |
Why?
|
Encyclopedias as Topic | 1 | 2014 | 19 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 448 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 778 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2020 | 3419 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.030 |
Why?
|
Primary Health Care | 1 | 2009 | 4673 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14676 | 0.020 |
Why?
|
Physical Examination | 1 | 2017 | 1255 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20600 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8519 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5249 | 0.020 |
Why?
|
Heart Diseases | 1 | 2003 | 2795 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20981 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2006 | 14607 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2709 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2175 | 0.020 |
Why?
|
Geography | 1 | 2010 | 652 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2393 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2814 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3441 | 0.020 |
Why?
|
Leukocytosis | 1 | 2006 | 251 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.010 |
Why?
|
Pneumonia | 1 | 2016 | 2142 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5971 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5828 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3196 | 0.010 |
Why?
|
Triage | 1 | 2005 | 984 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27097 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5869 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36418 | 0.000 |
Why?
|